Literature DB >> 30883216

Non-Antibody-Secreting Functions of B Cells and Their Contribution to Autoimmune Disease.

Andrew Getahun1,2, John C Cambier1,2.   

Abstract

B cells play multiple important roles in the pathophysiology of autoimmune disease. Beyond producing pathogenic autoantibodies, B cells can act as antigen-presenting cells and producers of cytokines, including both proinflammatory and anti-inflammatory cytokines. Here we review our current understanding of the non-antibody-secreting roles that B cells may play during development of autoimmunity, as learned primarily from reductionist preclinical models. Attention is also given to concepts emerging from clinical studies using B cell depletion therapy, which shed light on the roles of these mechanisms in human autoimmune disease.

Entities:  

Keywords:  B cell depletion; B cells; T cells; antigen presentation; autoimmune; cytokine

Mesh:

Substances:

Year:  2019        PMID: 30883216      PMCID: PMC9553839          DOI: 10.1146/annurev-cellbio-100617-062518

Source DB:  PubMed          Journal:  Annu Rev Cell Dev Biol        ISSN: 1081-0706            Impact factor:   11.902


  154 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

Review 2.  Natural autoantibodies and associated B cells in immunity and autoimmunity.

Authors:  Kaiissar Mannoor; Yang Xu; Ching Chen
Journal:  Autoimmunity       Date:  2013-01-10       Impact factor: 2.815

3.  Circulating levels of B lymphocyte stimulator in patients with rheumatoid arthritis following rituximab treatment: relationships with B cell depletion, circulating antibodies, and clinical relapse.

Authors:  Geraldine Cambridge; William Stohl; Maria J Leandro; Thi-Sau Migone; David M Hilbert; Jonathan C W Edwards
Journal:  Arthritis Rheum       Date:  2006-03

4.  Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients.

Authors:  Anne H Cross; Jennifer L Stark; Joanne Lauber; Michael J Ramsbottom; Jeri-Anne Lyons
Journal:  J Neuroimmunol       Date:  2006-08-14       Impact factor: 3.478

5.  The anti-CD20 antibody rituximab reduces the Th17 cell response.

Authors:  Frank L van de Veerdonk; Bernard Lauwerys; Renoud J Marijnissen; Kim Timmermans; Franco Di Padova; Marije I Koenders; Ilse Gutierrez-Roelens; Patrick Durez; Mihai G Netea; Jos W M van der Meer; Wim B van den Berg; Leo A B Joosten
Journal:  Arthritis Rheum       Date:  2011-06

6.  The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors.

Authors:  Pablo A Silveira; Ellis Johnson; Harold D Chapman; Thi Bui; Roland M Tisch; David V Serreze
Journal:  Eur J Immunol       Date:  2002-12       Impact factor: 5.532

7.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

8.  Silencing of high-affinity insulin-reactive B lymphocytes by anergy and impact of the NOD genetic background in mice.

Authors:  Mia J Smith; Rochelle M Hinman; Andrew Getahun; Soojin Kim; Thomas A Packard; John C Cambier
Journal:  Diabetologia       Date:  2018-09-25       Impact factor: 10.122

9.  Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors.

Authors:  K L Rock; B Benacerraf; A K Abbas
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

10.  NFκB1 is essential to prevent the development of multiorgan autoimmunity by limiting IL-6 production in follicular B cells.

Authors:  Elisha de Valle; George Grigoriadis; Lorraine A O'Reilly; Simon N Willis; Mhairi J Maxwell; Lynn M Corcoran; Evelyn Tsantikos; Jasper K S Cornish; Kirsten A Fairfax; Ajithkumar Vasanthakumar; Mark A Febbraio; Margaret L Hibbs; Marc Pellegrini; Ashish Banerjee; Philip D Hodgkin; Axel Kallies; Fabienne Mackay; Andreas Strasser; Steve Gerondakis; Raffi Gugasyan
Journal:  J Exp Med       Date:  2016-03-28       Impact factor: 14.307

View more
  12 in total

Review 1.  Endotypes in T1D: B lymphocytes and early onset.

Authors:  Mia J Smith; John C Cambier; Peter A Gottlieb
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2020-08       Impact factor: 3.243

Review 2.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

3.  B Lymphocytes Contribute to Celiac Disease Pathogenesis.

Authors:  Thomas Lejeune; Celine Meyer; Valérie Abadie
Journal:  Gastroenterology       Date:  2021-03-02       Impact factor: 22.682

Review 4.  A Review of the Various Roles and Participation Levels of B-Cells in Non-Infectious Uveitis.

Authors:  Lei Zhu; Binyao Chen; Wenru Su
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

5.  B Lymphocytes Are the Target of Mesenchymal Stem Cells Immunoregulatory Effect in a Murine Graft-versus-Host Disease Model.

Authors:  Di Lu; Tian Ma; XiangBin Zhou; YanMing Jiang; Yan Han; Hong Li
Journal:  Cell Transplant       Date:  2019-07-01       Impact factor: 4.064

6.  Footprints of Immune Cells in the Pancreas in Type 1 Diabetes; to "B" or Not to "B": Is That Still the Question?

Authors:  Pia Leete; Noel G Morgan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-02-25       Impact factor: 5.555

7.  Trypanosoma cruzi Induces B Cells That Regulate the CD4+ T Cell Response.

Authors:  Martín Somoza; Adriano Bertelli; Cecilia A Pratto; Ramiro E Verdun; Oscar Campetella; Juan Mucci
Journal:  Front Cell Infect Microbiol       Date:  2022-01-05       Impact factor: 5.293

8.  Heterozygous OAS1 gain-of-function variants cause an autoinflammatory immunodeficiency.

Authors:  Thomas Magg; Tsubasa Okano; Lars M Koenig; Daniel F R Boehmer; Samantha L Schwartz; Kento Inoue; Jennifer Heimall; Francesco Licciardi; Julia Ley-Zaporozhan; Ronald M Ferdman; Andrés Caballero-Oteyza; Esther N Park; Brenda M Calderon; Debayan Dey; Hirokazu Kanegane; Kazutoshi Cho; Davide Montin; Karl Reiter; Matthias Griese; Michael H Albert; Meino Rohlfs; Paul Gray; Christoph Walz; Graeme L Conn; Kathleen E Sullivan; Christoph Klein; Tomohiro Morio; Fabian Hauck
Journal:  Sci Immunol       Date:  2021-06-18

9.  The Irony of Humanization: Alemtuzumab, the First, But One of the Most Immunogenic, Humanized Monoclonal Antibodies.

Authors:  David Baker; Liaqat Ali; Gauri Saxena; Gareth Pryce; Meleri Jones; Klaus Schmierer; Gavin Giovannoni; Sharmilee Gnanapavan; Kathleen C Munger; Lawrence Samkoff; Andrew Goodman; Angray S Kang
Journal:  Front Immunol       Date:  2020-02-14       Impact factor: 7.561

10.  Abnormal B-Cell and Tfh-Cell Profiles in Patients With Parkinson Disease: A Cross-sectional Study.

Authors:  Rui Li; Thomas Francis Tropea; Laura Rosa Baratta; Leah Zuroff; Maria E Diaz-Ortiz; Bo Zhang; Koji Shinoda; Ayman Rezk; Roy N Alcalay; Alice Chen-Plotkin; Amit Bar-Or
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.